Her main research line, hunting viruses from the environment to be used in biomedicine, promotes phages as a promising alternative treatment against multidrug-resistant bacteria, allowing her to combine her expertise in phage biology and biomedicine. Phages are ubiquitous in the environment and immensely diverse, making phage discovery a powerful source of new therapies against pathogenic bacteria. She has been recently awarded an ESCMID Research Grant 2020 to pursue her research in phage therapy to combat Klebsiella pneumoniae, one of the high-risk infectious diseases due to the emergence of multidrug-resistant strains. She is member of the Spanish phage network (FAGOMA), the American Society for Microbiology, the Sociedad Española de Virología, and the ESCMID. Additionally, she has signed transfer agreements and established collaborations with national hospitals, which will allow her to directly explore phage therapy in the clinical setting, mainly as compassionate use. Recently, the SARS-CoV-2 pandemic has led her to conduct epidemiological surveillance studies of the virus through sewage and to study a possible indirect transmission route through the environment, being the PI of a FONDO COVID-19 grant (ISCIII), and the possible fecal-oral transmission, as PI of a CSIC-COVID-19 grant (CSIC). She is PI of more than 10 transfer contracts with private companies, including COVID-19 research (surveillance and antivirals) and phage therapy. Finally, it is worth to mention her teaching activities, mainly in Genetics, Evolution, Virology, and Phage Therapy at UV, Universidad Complutense de Madrid, Howest International University, Université Franche-Comté, and Université de Strasbourg. She is certified to the figure “Contratado Doctor”.